MORNING LIGHT IP
January 21, 2021
IC 009. US 021 023 026 036 038. G & S Downloadable software in the nature of a mobile application for confirming identity and current COVID-19 status.
IC 042. US 100 101. G & S Providing temporary use of non-downloadable software to confirm identity and current COVID-19 status for purpose of entry to buildings, offices, labs, classrooms, restaurants, sporting events, social events and entertainment venues.
IC 045. US 100 101. G & S Identification verification services, namely, providing authentication of personal identification information and COVID-19 status for purpose of entry to buildings, offices, labs, classrooms, restaurants, sporting events, social events and entertainment venues.
IC 044. US 100 101. G & S Medical testing of blood and saliva; Medical testing for coronavirus.
IC 044. US 100 101. G & S Medical testing of blood and saliva; Medical testing for coronavirus.
IC 044. US 100 101. G & S Medical testing of blood and saliva; Medical testing for coronavirus.
IC 036. US 100 101 102. G & S Financial services, namely, funding research in the fields of science, medicine and healthcare; Venture capital funding services to scientists and start-up companies; Funding of scientific, medical and healthcare research.
IC 042. US 100 101. G & S Providing laboratory facilities for scientific and medical research; Rental of laboratory facilities; Leasing of laboratories containing laboratory equipment for medical and scientific research; Rental of laboratory apparatus and instruments; Scientific and medical research.
IC 035. US 100 101 102. G & S Rental of office machinery and equipment.
IC 036. US 100 101 102. G & S Rental of office space.
IC 040. US 100 103 106. G & S Manufacturing services for others in the fields of biological products, biopharmaceutical products, regenerative medicine products, combination biologic/device products, or viral and non-viral vectors for use in gene therapy, modified gene therapy, cell therapy, tissue engineering; Manufacturing services for others in the fields of biopharmaceuticals; Manufacturing services for others in the fields of mammalian cell banks, plasmids, adenovirus, adeno-associated virus (AAV), bacteriophage, lentivirus, retroviruses and other viruses found in humans and animals; Manufacturing process consulting.
IC 042. US 100 101. G & S Rental of laboratory apparatus and instruments; Rental of laboratory equipment; Rental of laboratory instruments; Scientific laboratory services; Rental of laboratory facilities; Leasing of laboratories containing laboratory equipment for scientific research; Research and development services in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Consulting services in the fields of research and development for gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Research and development of new products for others; Process development services in the in the nature of research and development of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Scientific research and technical research services, namely, production of cell lines for others using lentivirus technology; Scientific research and technical research services relating to producing, assaying and purifying recombinant or manipulated lentivirus; Scientific and technical consulting services relating to producing, assaying, and purifying adenovirus, adeno-associated virus (AAV), bacteriophage, lentivirus, retroviruses and other viruses found in humans and animals; advisory services relating to research and development of gene therapy products and biopharmaceuticals; manufacturing support services for others, namely, cGMP (Current Good Manufacturing Practice) quality control testing in support of biopharmaceutical development and manufacturing; Quality control for others; Quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Material testing; Product quality testing; Scientific laboratory services; Scientific research.
IC 041. US 100 101 107. G & S Educational services, namely, providing classes and workshops in the field of advanced therapy medicinal products and genetic engineering; Educational services, namely, providing classes in the field of manufacturing and engineering of gene therapies, cell therapies and biopharmaceuticals ; Educational services, namely, training in connection with manufacturing and engineering of gene therapies, cell therapies and bio-pharmaceuticals.
IC 042. US 100 101. G & S Scientific laboratory services; Laboratory research services relating to pharmaceuticals; Consulting services in the fields of biotechnology, pharmaceutical research and development, and laboratory testing; Toxicology services; Scientific and technological services, namely, conducting toxicology studies, pharmacology studies, pharmacokinetic studies, proof of concept studies, and efficacy studies in the field of pharmaceutical research and development.
IC 040. US 100 103 106. G & S Manufacturing services for others in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Manufacturing services for others in the fields of mammalian cell banks, plasmids, adenovirus, adeno-associated virus (AAV), bacteriophage, lentivirus, retroviruses and other viruses found in humans and animals; Manufacturing process consulting.
IC 042. US 100 101. G & S Research and development services in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Consulting services in the fields of research and development for gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Research and development of new products for others; Process development services in the nature of research and development of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Scientific research and technical research services, namely, production of cell lines for others using lentivirus technology; Scientific research and technical research services relating to producing, assaying and purifying recombinant or manipulated lentivirus; Scientific and technical consulting services relating to producing, assaying, and purifying adenovirus, adeno-associated virus (AAV), bacteriophage, lentivirus, retroviruses and other viruses found in humans and animals; advisory services relating to research and development of gene therapy products and biopharmaceuticals; manufacturing support services for others, namely, cGMP (Current Good Manufacturing Practice) quality control testing in support of biopharmaceutical development and manufacturing; Quality control for others; Quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Material testing; Product quality testing; Scientific laboratory services; Scientific research.
IC 045. US 100 101. G & S Regulatory compliance consulting in the fields of pharmaceuticals, medicines, biopharmaceuticals, and gene therapy.
IC 040. US 100 103 106. G & S Manufacturing services for others in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Manufacturing services for others in the fields of mammalian cell banks, plasmids, adenovirus, adeno-associated virus (AAV), bacteriophage, lentivirus, retroviruses and other viruses found in humans and animals; Manufacturing process consulting.
IC 042. US 100 101. G & S Research and development services in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Consulting services in the fields of research and development for gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Research and development of new products for others; Process development services in the nature of research and development of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Scientific research and technical research services, namely, production of cell lines for others using lentivirus technology; Scientific research and technical research services relating to producing, assaying and purifying recombinant or manipulated lentivirus; Scientific and technical consulting services relating to producing, assaying, and purifying adenovirus, adeno-associated virus (AAV), bacteriophage, lentivirus, retroviruses and other viruses found in humans and animals; advisory services relating to research and development of gene therapy products and biopharmaceuticals; manufacturing support services for others, namely, cGMP (Current Good Manufacturing Practice) quality control testing in support of biopharmaceutical development and manufacturing; Quality control for others; Quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Material testing; Product quality testing; Scientific laboratory services; Scientific research.
IC 045. US 100 101. G & S Regulatory compliance consulting in the fields of pharmaceuticals, medicines, biopharmaceuticals, and gene therapy.
IC 040. US 100 103 106. G & S Manufacturing services for others in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Manufacturing services for others in the fields of mammalian cell banks, plasmids, adenovirus, adeno-associated virus (AAV), bacteriophage, lentivirus, retroviruses and other viruses found in humans and animals; Manufacturing process consulting.
IC 042. US 100 101. G & S Research and development services in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Consulting services in the fields of research and development for gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Research and development of new products for others; Process development services in the nature of research and development of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Scientific research and technical research services, namely, production of cell lines for others using lentivirus technology; Scientific research and technical research services relating to producing, assaying and purifying recombinant or manipulated lentivirus; Scientific and technical consulting services relating to producing, assaying, and purifying adenovirus, adeno-associated virus (AAV), bacteriophage, lentivirus, retroviruses and other viruses found in humans and animals; advisory services relating to research and development of gene therapy products and biopharmaceuticals; manufacturing support services for others, namely, cGMP (Current Good Manufacturing Practice) quality control testing in support of biopharmaceutical development and manufacturing; Quality control for others; Quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Material testing; Product quality testing; Scientific laboratory services; Scientific research.
IC 045. US 100 101. G & S Regulatory compliance consulting in the fields of pharmaceuticals, medicines, biopharmaceuticals, and gene therapy.
IC 036. US 100 101 102. G & S Real estate services, namely, the management and leasing of real estate. FIRST USE: 20170000. FIRST USE IN COMMERCE: 20180100.
IC 036. US 100 101 102. G & S Real estate services, namely, the management and leasing of real estate.
IC 005. US 006 018 044 046 051 052. G & S Pharmaceutical preparations and substances for treatment of upper and lower respiratory diseases and disorders; surfactant replacement therapies for respiratory diseases; pulmonary lung surfactants; inhaled pharmaceutical products for all human respiratory indications; respiratory stimulants. FIRST USE: 20080728. FIRST USE IN COMMERCE: 20080728.
IC 010. US 026 039 044. G & S [ Electric warming units for heating medication ]. FIRST USE: 20050414. FIRST USE IN COMMERCE: 20050630.